Bioxytran (BIXT) Other Accumulated Expenses (2011 - 2026)
Bioxytran (BIXT) posted Other Accumulated Expenses of $195,786 for Q2 2026, down 14.1% from $227,859 a year earlier but up 26.2% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Bioxytran's Other Accumulated Expenses came in at $114,534, up 53.7% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of -17.9% (FY2020 to FY2025).
- In prior years, Bioxytran's Other Accumulated Expenses was $74,504 in FY2024 (-66.7%), $223,759 in FY2023 (+23.9%), $180,557 in FY2022 (-66.0%) and $531,000 in FY2021 (+72.9%).
- Quarterly Other Accumulated Expenses has run from a low of $18,625 in Q3 2024 to a high of $1.06 million in Q2 2022 over five years.
- On a year-over-year basis, Other Accumulated Expenses increased in three of the last seven quarters, with growth averaging 58.6%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2025, with growth of 334.6%; the weakest was Q3 2024, with a decline of 90.0%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $155,160 (Q1 2026), $114,534 (Q4 2025) and $57,267 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 195,786.00 |
| Mar 31, 2026 | 155,160.00 |
| Dec 31, 2025 | 114,534.00 |
| Sep 30, 2025 | 57,267.00 |
| Jun 30, 2025 | 227,859.00 |
| Mar 31, 2025 | 182,482.00 |
| Dec 31, 2024 | 74,504.00 |
| Sep 30, 2024 | 18,625.00 |
| Jun 30, 2024 | 52,434.00 |
| Dec 31, 2023 | 223,759.00 |
| Sep 30, 2023 | 185,967.00 |
| Jun 30, 2023 | 181,548.00 |
| Mar 31, 2023 | 975,227.00 |
| Dec 31, 2022 | 180,557.00 |
| Sep 30, 2022 | 461,727.00 |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 796,506.00 |
| Dec 31, 2021 | 531,000.00 |
| Sep 30, 2021 | 338,826.00 |
| Mar 31, 2021 | 368,367.00 |
API Access
Bioxytran Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();